Research and Markets Releases 2022 Digital Biomarkers Drug Development Market Report
The "Growth Opportunities for Digital Biomarkers in Drug Development" report has been added to ResearchAndMarkets.com's offering. The study focuses on 3 major therapy areas, neurology, oncology, and cardiology, which digital biomarkers impact.
Key topics covered:
- Strategic Imperatives
- Growth Opportunity Analysis
- Growth Opportunity Analysis - Neurology
- Growth Opportunity Analysis - Oncology
- Regulatory Landscape
- Industry Assessment and Analysis
- Patent Landscape
- Growth Opportunity Universe
Read more about the report here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
